Hemerus Medical, LLC
Hemerus Medical, LLC specializes in designing and developing innovative blood collection, processing, preservation, and storage technologies. Our mission is to improve patient transfusion outcomes and ensure the availability of high-quality, life-saving blood products. Hemerus aims to extend the shelf life of blood products and enhance transfusion safety through advanced technologies like leukocyte reduction filters and novel anticoagulant and additive solutions.
Industries
Nr. of Employees
small (1-50)
Hemerus Medical, LLC
5000 Township Parkway, Saint Paul, MN 55110-5852, USA
Hemerus Medical, LLC is currently seeking investment
Hemerus Medical, LLC is seeking a series-a investment in the range of 5m-20m
Patents
Blood storage container containing aqueous composition for the storage of red blood cells
2024-12-31 • US-12178779-B2
View DetailsBlood storage container containing aqueous composition for the storage of red blood cells
2023-08-22 • US-11730676-B2
View Details
Blood storage container containing aqueous composition for the storage of red blood cells
2024-12-31 • US-12178779-B2
View DetailsBlood storage container containing aqueous composition for the storage of red blood cells
2023-08-22 • US-11730676-B2
View DetailsProducts
Blood collection and component processing system (includes RBC additive solution and filtration consumables)
Integrated system and consumable set for collection of CPD whole blood, pre-storage leukocyte reduction, preparation of red blood cells using an RBC additive solution that permits room-temperature hold up to 24 hours, and preparation/freezing of plasma under defined timelines.
Blood collection and component processing system (includes RBC additive solution and filtration consumables)
Integrated system and consumable set for collection of CPD whole blood, pre-storage leukocyte reduction, preparation of red blood cells using an RBC additive solution that permits room-temperature hold up to 24 hours, and preparation/freezing of plasma under defined timelines.
Expertise Areas
- Blood collection and processing
- Blood product preservation and storage
- Leukoreduction technologies
- Anticoagulant and additive solution development
Key Technologies
- Red blood cell additive solutions
- Anticoagulant formulations (CPD-based workflows)
- Leukoreduction filtration
- One-step vent-free processing circuits
Key People
News & Updates
Hemerus Medical received patents for developing DEHP-free blood collection and storage systems, addressing health and environmental concerns.
Hemerus Medical Receives CE Marking for World's First 56 Day Red Blood Cell Storage Solution - SOLX®
SOLX® was the result of a collaborative effort between the US Army, the University of Cincinnati and Hemerus. The SOLX® storage solution research was initially funded by the US Army, and invented by Dr. John Hess of the University of Maryland, and the late Dr. Tibor Greenwalt of the University of Cincinnati. Hemerus furthered this research through its development of a whole blood leukoreduction collection set and performed clinical trials, which were also partially funded by the US Army. Hemerus holds the exclusive worldwide license to the intellectual property.
The SOLX® system is a whole blood collection system that produces Leukoreduced red blood cells and plasma. This system has been approved in the United States by the FDA for six weeks red blood cell storage and was previously approved in Europe for eight weeks red blood cell storage.
Hemerus Medical, LLC, a leader in innovative blood collection, storage, and preservation technologies, announces its commitment to eliminating Substances of Very High Concern (SVHC), such as phthalate plasticizers like di(2-ethylhexyl) phthalate (DEHP) from blood collection and storage sets.
Hemerus Medical received patents for developing DEHP-free blood collection and storage systems, addressing health and environmental concerns.
Hemerus Medical Receives CE Marking for World's First 56 Day Red Blood Cell Storage Solution - SOLX®
SOLX® was the result of a collaborative effort between the US Army, the University of Cincinnati and Hemerus. The SOLX® storage solution research was initially funded by the US Army, and invented by Dr. John Hess of the University of Maryland, and the late Dr. Tibor Greenwalt of the University of Cincinnati. Hemerus furthered this research through its development of a whole blood leukoreduction collection set and performed clinical trials, which were also partially funded by the US Army. Hemerus holds the exclusive worldwide license to the intellectual property.
The SOLX® system is a whole blood collection system that produces Leukoreduced red blood cells and plasma. This system has been approved in the United States by the FDA for six weeks red blood cell storage and was previously approved in Europe for eight weeks red blood cell storage.
Hemerus Medical, LLC, a leader in innovative blood collection, storage, and preservation technologies, announces its commitment to eliminating Substances of Very High Concern (SVHC), such as phthalate plasticizers like di(2-ethylhexyl) phthalate (DEHP) from blood collection and storage sets.